Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;41(7):2347-2358.
doi: 10.1007/s10792-021-01788-z. Epub 2021 Mar 21.

Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases

Alfonso L Sabater  1 , Hazem M Mousa  2 , Xavier Quinones  1 , Felipe Valenzuela  1 , Ronald Mauricio Sanchez Avila  3 , Gorka Orive  4   5   6   7 , Eduardo Anitua  4   5 , Jesús Merayo  3 , Victor L Perez  8   9
Affiliations

Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases

Alfonso L Sabater et al. Int Ophthalmol. 2021 Jul.

Abstract

Purpose: To evaluate the safety and efficacy of the surgical use of autologous plasma rich in growth factors fibrin membrane (mPRGF) in improving corneal wound healing and regeneration in a variety of complex ocular surface defects.

Methods: Chart review on 15 eyes of 14 included patients undergoing ocular surface intervention using intraoperative mPRGF at the Bascom Palmer Eye Institute and at the Instituto Oftalmológico Fernández-Vega was performed. Patients were grouped based on type of intervention or condition (penetrating keratoplasty, superficial keratectomy, neurotrophic or persistent corneal ulcers, and corneal perforation). Patients were followed for an average of 11 ± 5 months. Main outcomes measured were mPRGF dissolving time, best-corrected visual acuity, and evidence of any persistent epithelial defects, rejections, or complications.

Results: All 15 eyes underwent successful placement of mPRGF. Average dissolving time for fibrin membrane was 21 ± 3 days. mPRGF resulted in total healing of the corneal defects in 13/15 (86.7%) of the treated eyes and partial healing in 2/15 (13.3%) eyes in which persistent epithelial defects were noted on follow-up. Visual acuity improvement was seen in 9/15 (60%) of the cases.

Conclusion: The use of autologous mPRGF in the healing and regeneration of the ocular surface is a secure and efficacious surgical option. Our data demonstrate that PRGF fibrin membrane should be contemplated as an important tool to optimize ocular surface regeneration in complex cases.

Keywords: Ocular surface disorders; PRGF; Penetrating keratoplasty; Plasma rich in growth factors; Wound healing.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Stern ME, Schaumburg CS, Dana R et al (2010) Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol 3:425–442. https://doi.org/10.1038/mi.2010.26 - DOI - PubMed - PMC
    1. Tan DT, Dart JK, Holland EJ, Kinoshita S (2012) Corneal transplantation. The Lancet 379:1749–1761. https://doi.org/10.1016/S0140-6736(12)60437-1 - DOI
    1. Tseng SCG, Espana EM, Kawakita T et al (2004) How does amniotic membrane work? Ocul Surf 2:177–187. https://doi.org/10.1016/S1542-0124(12)70059-9 - DOI - PubMed
    1. Anitua E, de la Fuente M, Muruzabal F et al (2015) Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. Exp Eye Res 135:118–126. https://doi.org/10.1016/j.exer.2015.02.016 - DOI - PubMed
    1. Malhotra C, Jain AK (2014) Human amniotic membrane transplantation: different modalities of its use in ophthalmology. WJT 4:111. https://doi.org/10.5500/wjt.v4.i2.111 - DOI - PubMed - PMC

Substances